Last updated: September 1, 2022
Sponsor: Alshimaa Abbas Mohamed Ebrahim
Overall Status: Active - Not Recruiting
Phase
4
Condition
Rash
Scalp Disorders
Inflammatory Comedones
Treatment
N/AClinical Study ID
NCT05218486
551/7/21
Ages 15-60 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Healthy persons of both sexes with moderate and severe acne.
- Age above 14 years.
Exclusion
Exclusion Criteria:
- Pregnant and lactating women, immunocompromised patients.
- History of chronic liver disease, hyperlipidemia, non-inflammatory acne conditions, ,history of neurologic disorders, history of neoplastic disorders, and history ofcardiac disease.
- History of systemic acne treatment for at least 4 weeks prior to inclusion and notopical treatments for at least 2 weeks.
- Cases with known hypersensitivity reaction to isotretinoin.
Study Design
Total Participants: 60
Study Start date:
August 01, 2021
Estimated Completion Date:
September 30, 2022
Study Description
Connect with a study center
Aswan university
Aswan, 81528
EgyptSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.